Danone Invests In Medical Nutrition Production Line In France

The Steenvoorde will be capable of producing up to 20 million litres of oral nutrition supplements per annum from 2026, Danone said, and has been developed in response to global health and patient needs.

The majority of the investment, around €60 million, will be used to develop close to 30 recipes of Danone’s oral nutritional supplement for patients, under the French food giant’s Nutricia specialised nutrition range.

The facility’s output will help deliver ‘better outcomes and quality of life’ for patients who suffer from disease related malnutrition, the company added.

According to the company, disease-related malnutrition, as a result of conditions such as cancer or strokes, or due to ageing, affects one in four patients that are admitted to hospital, however only one in three who need medical nutrition receive it.

New Biomass Boiler

In addition to the production line, Danone will invest €10 million in new infrastructure at the Steenvoorde site, including a biomass boiler.

This boiler will reduce the site’s carbon footprint by nearly 70%, aligning with Danone Impact Journey commitments and supported by its Re-Fuel energy excellence programme.

ESM